NCT05409989: An ongoing trial by Microvention-Terumo, Inc.
This trial is ongoing. It must report results 4 years, 9 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05409989 |
|---|---|
| Title | MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 20, 2022 |
| Completion date | Sept. 30, 2029 |
| Required reporting date | Sept. 30, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |